Anavex Life Sciences (AVXL) Tops Q1 EPS by 6c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• TechCreate Group faces NYSE American delisting proceedings